REGISTERED COMPANY NUMBER: 01676618 (England and Wales)
REGISTERED CHARITY NUMBER: 286197
Report of the Trustees and
Unaudited Financial Statements for the Year Ended 31 December 2023
for
British Toxicology Society(The)
BullockWoodburn Limited
Norfolk House
Hardwick Square North
Buxton
SK17 6PU
British Toxicology Society(The)
Contents of the Financial Statements for the Year Ended 31 December 2023
|
Page |
Report of the Trustees |
1 to 2 |
Independent Examiner's Report |
3 |
Statement of Financial Activities |
4 |
Balance Sheet |
5 to 6 |
Notes to the Financial Statements |
7 to 14 |
Detailed Statement of Financial Activities |
15 to 17 |
British Toxicology Society(The)
Report of the Trustees for the Year Ended 31 December 2023
ThetrusteeswhoarealsodirectorsofthecharityforthepurposesoftheCompaniesAct2006,presenttheir report
withthefinancialstatementsofthecharityfortheyearended31December2023.Thetrusteeshaveadopted the
provisionsofAccountingandReportingbyCharities:StatementofRecommendedPracticeapplicableto charities
preparingtheiraccountsinaccordancewiththeFinancialReportingStandardapplicableintheUKandRepublic of
Ireland (FRS 102) (effective 1 January 2019).
OBJECTIVES AND ACTIVITIES
Objectives and significant activities
TheSocietyisestablishedforthepromotionandadvancement,forthepublicbenefit,ofeducationinthescience of
toxicology.In decidingthe aims and activitiesof the society,the trusteeshave paiddue regardto the guidance issued
by the CharityCommissionon publicbenefit.Toxicologyis the scienceof diseaseinducedby chemicalspresentin the
diet,medicines,andintheenvironment.TheBritishToxicologySociety(BTS)isaleadinginternational toxicology
society,basedonthehighestqualityscience,andpromotestheadvancement,communicationandunderstanding of
the scientific disciplines necessary to foster public health and environmental safety.
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
The Societyis a companylimitedby guaranteeandthe liabilityof members is limitedto an amountnot exceeding £1.
ItisexemptunderSection60oftheCompaniesAct2006fromtherequirementtousetheword'Limited'inits title.
TheSocietyisgovernedbytheMemorandumandArticlesofAssociation.Itisregisteredwiththe Charities
Commission, number 286197, and no liability to taxation arises.
TheExecutiveCommitteeareDirectorsforthepurposeofcompanylawandTrusteesforthepurposeofcharity law.
Directors/TrusteesareappointedbytheSociety'smembersattheAnnualGeneralMeeting.WhenaTrustee retires,
theExecutiveCommitteenominatesnewTrustees.Additionalnominationsmaybemadebythe membership,
provided they are signed by six members of the Society.
InformalinductionproceduresareinplacefornewTrustees,conductedbyanexistingmemberofthe Executive
Committeeandtheyarealsoprovidedwithrelevantdocumentationtoformallyadviseandinformthemof the
Society's constitution and objectives and also their duties and responsibilities as a trustee.
OnethirdoftheExecutiveCommitteeordinarymembersretireeachyearinrotationbutaretheneligible for
re-election.ThesocietyisorganisedsothattheTrustees,intheformoftheExecutiveCommittee,meet regularly,
usuallyonaquarterlybasis,tomanageitsaffairs.Therearealsosub-committeeswhichareresponsiblefor advising
and researching the various activities and development of the Society, who report to the Executive Committee.
Statutesfor the workingsof the varioussub-committeesare continuallybeingrevisedand updatedto ensurethat the
termsofreferenceareclearlydefinedandthewaysofworkingareconsistent.Thisalsoenablestransparency of
committeeelectionsanddurationof membership,whileallowingthecommitteesto worktoagreedaims,backed up
by comprehensive set of Standard Operating Procedures for the Society.
ThetrusteeshaveassessedthemajorriskstowhichtheSocietyisexposed,inparticularthoserelatedto the
operations and finances of the Society, and are satisfied that systems are in place to mitigate exposure to major risks.
All of the officers and members who serve on the Society'scommitteesare unpaid.They are entitledto be reimbursed
for any out of pocket expenses incurred in attending meetings.
Norelatedparties,relatedpartytransactions,beneficialrelationshipsorconflictsofinterestrequiringdisclosure by
the Charities' or Companies' Acts existed during the year.
AttendancebyExecutiveCommitteemembershasbeenreasonablethroughouttheyear.Theco-opted members
continue to provide liaison with the relevant Sub-Committees and Speciality Sections.
The day to day administration of the Society is undertaken by an outside agency on a fee basis.
REFERENCE AND ADMINISTRATIVE DETAILS
Registered Company number
01676618 (England and Wales)
Registered Charity number
286197
Page 1
British Toxicology Society(The)
Report of the Trustees for the Year Ended 31 December 2023
Registered office
Executive Business Support Limited
City Wharf
Davidson Road
Lichfield
Staffordshire
WS14 9DZ
Trustees
Professor B G Lake Toxicologist
Dr E Marczylo Toxicologist
Dr D R Mason Toxicological Safety
Professor S C Price Professor Of Toxicology
Dr F Sewell Programme Manager
Dr P A Botham Toxicologist
Dr L M Reeve Toxicologist
Dr I Copple Senior Lecturer in Pharmacology
Dr B Ross Senior Consultant Toxicologist
Dr H Matar Associate Professor of Toxicology
Mrs F Hill Civil servant
Dr E Idahosa-Taylor Toxicologist (appointed 17/4/2023)
Company Secretary
Professor S C Price
Independent Examiner
Jonathon Dickens ACA
BullockWoodburn Limited
Norfolk House
Hardwick Square North
Buxton
SK17 6PU
Approved by order of the board of trustees on ............................................. and signed on its behalf by:
........................................................................
Mrs F Hill - Trustee
Page 2
Independent Examiner's Report to the Trustees of British Toxicology Society(The)
Independent examiner's report to the trustees of British Toxicology Society(The) ('the Company')
IreporttothecharitytrusteesonmyexaminationoftheaccountsoftheCompanyfortheyear ended
31 December 2023.
Responsibilities and basis of report
As the charity'strusteesof the Company(andalsoits directorsfor the purposesof companylaw)youare responsible
for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').
HavingsatisfiedmyselfthattheaccountsoftheCompanyarenotrequiredtobeauditedunderPart16ofthe 2006
Actandareeligibleforindependentexamination,I reportinrespectof my examinationof yourcharity'saccounts as
carriedoutunderSection145oftheCharitiesAct2011('the2011Act').IncarryingoutmyexaminationI have
followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act.
Independent examiner's statement
Ihavecompletedmyexamination.Iconfirmthatnomattershavecometomyattentioninconnectionwith the
examination giving me cause to believe:
1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or 2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or
4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).
Ihavenoconcernsandhavecomeacrossnoothermattersinconnectionwiththeexaminationtowhich attention
should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Jonathon Dickens ACA
BullockWoodburn Limited
Norfolk House
Hardwick Square North
Buxton
SK17 6PU
25 April 2024
Page 3
British Toxicology Society(The)
Statement of Financial Activities
for the Year Ended 31 December 2023
Unrestricted
fund
Notes
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
73,364
Charitable activities
Annual Congress
122,191
Annual Congress trade exhibition
3,970
PATDD, ACT joint meetings, webinars and online
events
10,790
Other trading activities
2
11,487
Investment income
3
7,378
Total
229,180
EXPENDITURE ON
Raising funds
4
42,463
Charitable activities
5
Annual Congress
137,856
Annual Congress trade exhibition
107
PATDD, ACT joint meetings, webinars and online
events
-
Donations and subscriptions to other societies
7,232
Travel bursaries and early career support
7,701
Other
23,610
Total
218,969
NET INCOME/(EXPENDITURE)
10,211
RECONCILIATION OF FUNDS
Total funds brought forward
373,414
TOTAL FUNDS CARRIED FORWARD
383,625 |
Restricted
funds
£
-
-
-
-
-
90
90
-
-
-
-
-
-
-
-
90
10,014
10,104 |
2023
Total
funds
£
73,364
122,191
3,970
10,790
11,487
7,468
229,270
42,463
137,856
107
-
7,232
7,701
23,610
218,969
10,301
383,428
393,729 |
2022
Total
funds
£
65,250
88,325
360
15,080
8,561
843
178,419
30,779
91,745
7
26,421
7,455
4,210
23,848
184,465
(6,046)
389,474
383,428 |
|
|
|
|
The notes form part of these financial statements
Page 4
British Toxicology Society(The)
Balance Sheet
31 December 2023
Unrestricted
fund
Notes
£
CURRENT ASSETS
Debtors
9
65,125
Cash at bank
387,495
452,620
CREDITORS
Amounts falling due within one year
10
(68,995)
NET CURRENT ASSETS
383,625
TOTAL ASSETS LESS CURRENT LIABILITIES
383,625
NET ASSETS
383,625
FUNDS
11
Unrestricted funds
Restricted funds
TOTAL FUNDS |
Restricted
funds
£
-
10,104
10,104
-
10,104
10,104
10,104 |
2023
Total
funds
£
65,125
397,599
462,724
(68,995)
393,729
393,729
393,729
383,625
10,104
393,729 |
2022
Total
funds
£
27,163
368,975
396,138
(12,710)
383,428
383,428
383,428
373,414
10,014
383,428 |
|
|
|
|
The charitablecompanyis entitledto exemptionfrom audit under Section477 of the CompaniesAct 2006 for the year
ended 31 December 2023.
Themembershavenotrequiredthecompanytoobtainanauditofitsfinancialstatementsfortheyear ended
31 December 2023 in accordance with Section 476 of the Companies Act 2006.
The trustees acknowledge their responsibilities for
-
(a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
-
(b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.
The notes form part of these financial statements
continued...
Page 5
British Toxicology Society(The)
Balance Sheet - continued
31 December 2023
Thesefinancialstatementshavebeenpreparedinaccordancewiththeprovisionsapplicabletocharitable companies
subject to the small companies regime.
ThefinancialstatementswereapprovedbytheBoardofTrusteesandauthorisedforissue on
............................................. and were signed on its behalf by:
.............................................
F Hill - Trustee
.............................................
S C Price - Trustee
The notes form part of these financial statements
Page 6
British Toxicology Society(The)
Notes to the Financial Statements
for the Year Ended 31 December 2023
1. ACCOUNTING POLICIES
Basis of preparing the financial statements
The financialstatementsof the charitablecompany,whichis a publicbenefitentityunderFRS 102,have been
preparedinaccordancewiththeCharitiesSORP(FRS102)'AccountingandReportingbyCharities: Statement
ofRecommendedPracticeapplicabletocharitiespreparingtheiraccountsinaccordancewiththe Financial
ReportingStandardapplicablein the UK and Republicof Ireland(FRS 102) (effective1 January2019)', Financial
ReportingStandard102 'The FinancialReportingStandardapplicablein the UK and Republicof Ireland'and the
Companies Act 2006. The financial statements have been prepared under the historical cost convention.
Going concern
There are no material uncertainties about the charity's ability to continue.
Thetrustees'assessmentoftherisksassociatedwithBrexitandthepandemicaredetailedinthe President's
report.
Financial reporting standard 102 - reduced disclosure exemptions
Thecharitablecompanyhastakenadvantageofthefollowingdisclosureexemptionsinpreparing these
financialstatements,aspermittedbyFRS102'TheFinancialReportingStandardapplicableintheUK and
Republic of Ireland':
-
the requirements of Section 7 Statement of Cash Flows;
-
the requirement of paragraph 3.17(d);
-
the requirements of paragraphs 11.42, 11.44, 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);
-
the requirements of paragraphs 12.26, 12.27, 12.29(a), 12.29(b) and 12.29A;
-
the requirement of paragraph 33.7.
Income
All incomingresourcesare includedin the statementof financialactivitieswhen entitlementhas passedto the
charity;itisprobablethattheeconomicbenefitsassociatedwiththetransactionwillflowtothecharity and
theamountcanbereliablymeasured.Thefollowingspecificpoliciesareappliedtoparticularcategories of
income:
-Incomefromdonationsorgrantsisrecognisedwhenthereisevidenceofentitlementtothegift,receipt is
probable and its amount can be measured reliably.
- Legacy income is recognised when receipt is probable and entitlement is established.
- Incomefromdonatedgoodsismeasuredatthefairvalueofthegoodsunlessthisisimpracticalto measure
reliably,inwhichcasethevalueisderivedfromthecosttothedonorortheestimatedresalevalue. Donated
facilitiesandservicesarerecognisedintheaccountswhenreceivedifthevaluecanbereliablymeasured. No
amounts are included for the contribution of general volunteers.
- Income from contractsfor the supplyof services is recognisedwith the delivery of the contractedservice. This
isclassifiedasunrestrictedfundsunlessthereisacontractualrequirementforittobespentona particular
purpose and returned if unspent, in which case it may be regarded as restricted.
Expenditure
Expenditureisrecognisedonanaccrualsbasisasaliabilityisincurred.ExpenditureincludesanyVAT which
cannotbefullyrecovered,andisclassifiedunderheadingsofthestatementoffinancialactivitiestowhich it
relates:
-Expenditureonraisingfundsincludesthecostsofallfundraisingactivities,events,non-charitable trading
activities, and the sale of donated goods.
continued...
Page 7
British Toxicology Society(The)
Notes to the Financial Statements - continued
for the Year Ended 31 December 2023
1. ACCOUNTING POLICIES - continued
Expenditure
-Expenditureoncharitableactivitiesincludesallcostsincurredbyacharityinundertakingactivities that
furtherits charitableaims for the benefit of its beneficiaries,includingthose supportcosts and costs relating to
the governance of the charity apportioned to charitable activities.
- Otherexpenditureincludesallexpenditurethatis neitherrelatedtoraisingfundsforthecharitynorpart of
its expenditure on charitable activities.
All costsare allocatedto expenditurecategoriesreflectingthe use of the resource.Directcostsattributable to
a singleactivityare allocateddirectlyto that activity.Sharedcosts are apportionedbetweenthe activities they
contribute to on a reasonable, justifiable and consistent basis.
Taxation
The charity is exempt from corporation tax on its charitable activities.
Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
Restrictedfundscanonlybeusedforparticularrestrictedpurposeswithintheobjectsofthe charity.
Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.
Furtherexplanationofthenatureandpurposeofeachfundisincludedinthenotestothe financial
statements.
2. OTHER TRADING ACTIVITIES
OTHER TRADING ACTIVITIES |
|
|
Unrestricted
Restricted
funds
funds
£
£
Website advertising
9,667
-
OUP / RSC Journal income
1,820
-
11,487
- |
2023
Total
funds
£
9,667
1,820
11,487 |
2022
Total
funds
£
6,901
1,660 |
|
|
8,561 |
3. INVESTMENT INCOME
INVESTMENT INCOME |
|
|
|
|
|
|
|
2023 |
2022 |
|
Unrestricted |
Restricted |
Total |
Total |
|
funds |
funds |
funds |
funds |
|
£ |
£ |
£ |
£ |
Deposit account interest |
7,378 |
90 |
7,468 |
843 |
continued...
Page 8
British Toxicology Society(The)
Notes to the Financial Statements - continued
for the Year Ended 31 December 2023
4. RAISING FUNDS
Raising donations and legacies
Raising donations and legacies |
|
|
|
|
Unrestricted
funds
£
Bank charges
1,151
EBS - membership processing
11,677
Support costs
7,721
20,549
Other trading activities
Unrestricted
funds
£
EBS- website management
20,059
ACT webinars
1,015
AIT webinars
-
Bank charges
90
Ambassadors scheme
-
Support costs
750
21,914
Aggregate amounts
42,463
5.
CHARITABLE ACTIVITIES COSTS
Annual Congress
Annual Congress trade exhibition
Donations and subscriptions to other
societies
Travel bursaries and early career
support |
Restricted
funds
£
-
-
-
-
Restricted
funds
£
-
-
-
-
-
-
-
-
Direct
Costs
£
137,812
107
5,946
7,701
151,566 |
2023
Total
funds
£
1,151
11,677
7,721
20,549
2023
Total
funds
£
20,059
1,015
-
90
-
750
21,914
42,463
Support
costs (see
note 6)
£
44
-
1,286
-
1,330 |
2022
Total
funds
£
817
11,176
7,391
19,384
2022
Total
funds
£
9,134
662
1,000
56
543
-
11,395
30,779
Totals
£
137,856
107
7,232
7,701 |
2022
Total
funds
£
817
11,176
7,391 |
|
|
|
|
19,384 |
|
|
|
|
2022
Total
funds
£
9,134
662
1,000
56
543
- |
|
|
|
|
11,395 |
|
|
|
|
30,779 |
|
|
|
152,896 |
|
continued...
Page 9
British Toxicology Society(The)
Notes to the Financial Statements - continued
for the Year Ended 31 December 2023
6. SUPPORT COSTS
SUPPORT COSTS |
|
|
|
|
|
|
|
|
Information |
|
Management |
|
Finance |
technology |
|
£ |
|
£ |
£ |
Raising donations and legacies |
|
- |
7,721 |
- |
Other trading activities |
|
- |
- |
- |
Other resources expended |
8,463 |
|
6,436 |
2,686 |
Annual Congress |
44 |
|
- |
- |
Donations and subscriptions to other |
|
|
|
|
societies |
|
- |
1,286 |
- |
|
8,507 |
|
15,443 |
2,686 |
|
|
|
Governance |
|
|
Other |
|
costs |
Totals |
|
£ |
|
£ |
£ |
Raising donations and legacies |
|
- |
- |
7,721 |
Other trading activities |
750 |
|
- |
750 |
Other resources expended |
|
- |
6,025 |
23,610 |
Annual Congress |
|
- |
- |
44 |
Donations and subscriptions to other |
|
|
|
|
societies |
|
- |
- |
1,286 |
|
750 |
|
6,025 |
33,411 |
7. TRUSTEES' REMUNERATION AND BENEFITS
There were no trustees'remunerationor other benefitsfor the year ended 31 December 2023 nor for the year
ended 31 December 2022.
Trustees' expenses
Trustees' expenses
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted
fund
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
65,250
Charitable activities
Annual Congress
88,325
Annual Congress trade exhibition
360
PATDD, ACT joint meetings, webinars and
online events
15,080
Other trading activities
8,561
Investment income
812
Total
178,388 |
2023
£
187
Restricted
funds
£
-
-
-
-
-
31
31 |
2022
£
540
Total
funds
£
65,250
88,325
360
15,080
8,561
843 |
2022
£
540
Total
funds
£
65,250
88,325
360
15,080
8,561
843 |
|
|
|
178,419 |
8. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
continued...
Page 10
British Toxicology Society(The)
Notes to the Financial Statements - continued for the Year Ended 31 December 2023
8.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted
fund
£
EXPENDITURE ON
Raising funds
30,779
Charitable activities
Annual Congress
91,745
Annual Congress trade exhibition
7
PATDD, ACT joint meetings, webinars and
online events
26,421
Donations and subscriptions to other
societies
7,455
Travel bursaries and early career support
4,210
Other
23,848
Total
184,465
NET INCOME/(EXPENDITURE)
(6,077)
RECONCILIATION OF FUNDS
Total funds brought forward
379,491
TOTAL FUNDS CARRIED FORWARD
373,414
9.
DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Debtors
Prepayments & accrued income |
Restricted
funds
£
-
-
-
-
-
-
-
-
31
9,983
10,014
2023
£
6,073
59,052
65,125 |
Total
funds
£
30,779
91,745
7
26,421
7,455
4,210
23,848
184,465
(6,046)
389,474
383,428
2022
£
3,014
24,149
27,163 |
|
|
|
continued...
Page 11
British Toxicology Society(The)
Notes to the Financial Statements - continued
for the Year Ended 31 December 2023
10. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Trade creditors
Accruals & prepaid income
MOVEMENT IN FUNDS
Unrestricted funds
General fund
Restricted funds
Barnes fund
Paton fund
Norman Aldridge fund
TOTAL FUNDS
Net movement in funds, included in the above are as follows:
Unrestricted funds
General fund
Restricted funds
Barnes fund
Paton fund
Norman Aldridge fund
TOTAL FUNDS |
At 1/1/23
£
373,414
813
3,777
5,424
10,014
383,428
Incoming
resources
£
229,180
1
35
54
90
229,270 |
2023
2022
£
£
52,680
4,689
16,315
8,021
68,995
12,710
Net
movement
At
in funds
31/12/23
£
£
10,211
383,625
1
814
35
3,812
54
5,478
90
10,104
10,301
393,729
Resources
Movement
expended
in funds
£
£
(218,969)
10,211
-
1
-
35
-
54
-
90
(218,969)
10,301 |
|
|
|
11. MOVEMENT IN FUNDS
continued...
Page 12
British Toxicology Society(The)
Notes to the Financial Statements - continued
for the Year Ended 31 December 2023
11. MOVEMENT IN FUNDS - continued
Comparatives for movement in funds
At 1/1/22
£
Unrestricted funds
General fund
379,491
Restricted funds
Barnes fund
812
Paton fund
3,770
Norman Aldridge fund
5,401
9,983
TOTAL FUNDS
389,474
Comparative net movement in funds, included in the above are as follows:
Incoming
resources
£
Unrestricted funds
General fund
178,388
Restricted funds
Barnes fund
1
Paton fund
7
Norman Aldridge fund
23
31
TOTAL FUNDS
178,419 |
Net
movement
At
in funds
31/12/22
£
£
(6,077)
373,414
1
813
7
3,777
23
5,424
31
10,014
(6,046)
383,428
Resources
Movement
expended
in funds
£
£
(184,465)
(6,077)
-
1
-
7
-
23
-
31
(184,465)
(6,046) |
|
|
Restrictedfundscomprisedonationsgiven to providelectureawards,travelgrantsand supportto early career
toxicologists. Awards are made by the trustees on an alternate year basis.
continued...
Page 13
British Toxicology Society(The)
Notes to the Financial Statements - continued
for the Year Ended 31 December 2023
12. RELATED PARTY DISCLOSURES
There were no related party transactions.
Page 14
British Toxicology Society(The)
Detailed Statement of Financial Activities for the Year Ended 31 December 2023
Unrestricted
Restricted
funds
funds
£
£
INCOME AND ENDOWMENTS
Donations and legacies
Donations
13,000
-
Subscriptions
60,364
-
73,364
-
Other trading activities
Website advertising
9,667
-
OUP / RSC Journal income
1,820
-
11,487
-
Investment income
Deposit account interest
7,378
90
Charitable activities
Annual Congress delegates
117,881
-
Annual Congress donations
5,100
-
Annual Congress exhibitors and trade stands
3,970
-
PATDD & ACT joint meetings & webinars
10,000
-
136,951
-
Total incoming resources
229,180
90
EXPENDITURE
Raising donations and legacies
Bank charges
1,151
-
EBS - membership processing
11,677
-
12,828
-
Other trading activities
EBS- website management
20,059
-
ACT webinars
1,015
-
AIT webinars
-
-
Bank charges
90
-
Ambassadors scheme
-
-
21,164
-
Charitable activities
Insurance
1,338
-
Carried forward
1,338
- |
2023
Total
funds
£
13,000
60,364
73,364
9,667
1,820
11,487
7,468
117,881
5,100
3,970
10,000
136,951
229,270
1,151
11,677
12,828
20,059
1,015
-
90
-
21,164
1,338
1,338 |
2022
Total
funds
£
10,050
55,200 |
|
|
65,250
6,901
1,660 |
|
|
8,561
843
84,425
3,900
360
15,080 |
|
|
103,765 |
|
|
178,419
817
11,176 |
|
|
11,993
9,134
662
1,000
56
543 |
|
|
11,395
908
908 |
This page does not form part of the statutory financial statements
Page 15
British Toxicology Society(The)
Detailed Statement of Financial Activities for the Year Ended 31 December 2023
Unrestricted
Restricted
funds
funds
£
£
Charitable activities
Brought forward
1,338
-
Entertainment
1,841
-
Security
-
-
Speakers' expenses
3,748
-
Delegate materials
991
-
Accommodation and meals
93,086
-
Technicians and equipment hire
15,017
-
Bank charges
288
-
EBS management fee
17,892
-
EBS travel expenses
192
-
EBS processing fees
3,179
-
Eurotox subscription
1,910
-
Understanding Animal Research
291
-
Society of Biology
660
-
Iutox International
3,032
-
Early career prizes
-
-
Travel bursary
6,587
-
Oral presentation prize
300
-
Recognition awards
653
-
Poster presentation prize
100
-
NEST promotional materials
461
-
151,566
-
Support costs
Management
Postage and stationery
214
-
EBS- trustee support
8,293
-
8,507
-
Finance
EBS- bookkeeping & finance
15,443
-
Information technology
EBS- licences & IT support
2,686
-
EDIS membership contribution
-
-
2,686
-
Other
Provision for doubtful debt
750
-
Governance costs
Meeting expenses - trustees
187
-
Carried forward
187
- |
2023
Total
funds
£
1,338
1,841
-
3,748
991
93,086
15,017
288
17,892
192
3,179
1,910
291
660
3,032
-
6,587
300
653
100
461
151,566
214
8,293
8,507
15,443
2,686
-
2,686
750
187
187 |
2022
Total
funds
£
908
1,188
880
1,439
226
61,873
11,928
68
10,832
456
2,456
1,668
277
690
3,059
777
1,690
200
-
300
1,722 |
|
|
102,637
635
7,934 |
|
|
8,569
14,782
3,801
500 |
|
|
4,301
-
540
540 |
This page does not form part of the statutory financial statements
Page 16
British Toxicology Society(The)
Detailed Statement of Financial Activities for the Year Ended 31 December 2023
Unrestricted
Restricted
funds
funds
£
£
Governance costs
Brought forward
187
-
Accountancy fees
5,415
-
Meeting expenses- non trustees
423
-
Project co-ordinator
-
-
6,025
-
Total resources expended
218,969
-
Net (expenditure)/income
10,211
90 |
2023
Total
funds
£
187
5,415
423
-
6,025
218,969
10,301 |
2022
Total
funds
£
540
5,248
-
25,000
30,788
184,465
(6,046) |
|
|
|
This page does not form part of the statutory financial statements
Page 17